Europe, South America, New Products; Yield Growth Corp

New Post Public Reply Private Reply Replies (0) Message Board
nlightn
222
Europe, South America, New Products; Yield Growth Corp Growing at Light Speed
CFN Media
Wed September 18, 2019

Seattle, Washington--(Newsfile Corp. - September 18, 2019) - CFN Media Group ("CFN Media" , the leading agency and financial media network dedicated to the North American cannabis (USMJ) industry, announces publication of an article covering The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) and its impressive global business plan.

47866_cfnyieldphotoresized.jpg


In the exploding cannabidiol (CBD) market, he who hesitates gets left behind. Companies like The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) are laser-focused and moving with a purpose to plant their flag in global markets forecast by leading cannabis researchers BDS Analytics and Arcview Market Research to exceed $20 billion in less than five years.

CBD, which doesn't get a person "high" like THC (tetrahydrocannabinol), is a component of cannabis sativa that is widely trumpeted for a bevy of therapeutic benefits from cancer therapy to skincare. Hemp, which became legal in the U.S. at the start of 2019 and is already legal in dozens of countries worldwide, is defined as cannabis sativa containing less than 0.3% THC.

Canada, Yield Growth's home country, is poised to have its CBD market burst onto the scenes later this year when beverages, edibles and topical CBD products from cannabis become legal.

As it stands, demand for CBD products is booming and the global "green rush" to bring new products to market is on. As evidenced by a non-stop stream of developments and deal flow, The Yield Growth Corp. is in the thick of it with its seasoned management and portfolio of brands, including Urban Juve, Wright & Well and UJ Beverages, as well as its manufacturing unit, W&W Manufacturing, and its strategies business, Thrive Activations.

C$3.7 Million in Deals, More Products on Deck

In addition to its own products, Yield Growth has a successful licensing and white label business that has generated C$3.7 million in signed agreements in 14 months. These agreements demonstrate the breadth of the company's domain. One was for three-year exclusive rights to distribute brands and infuse products with CBD and THC in Greece and Cyprus. Another was for U.S. rights to infuse products with CBD and THC, a third was for international rights to products for a hemp-infused men's line and a fourth covered European rights to infuse formulas with CBD.

Part of the reason for the success is owed to the company checking all the boxes for current consumers trends in cannabinoids (i.e. CBD, THC) and beauty and wellness products. Yield Growth's formulas are made from a proprietary extraction technology and are designed to be infused with cannabinoids thought to be beneficial to the body. Giving consumers what they want, all products are made from natural, pure ingredients, are cruelty-free, contaminant-free and contain only high-quality essential oils and botanical extracts.

Analysts at Jeffries are bullish on the CBD health and beauty market, forecasting it to reach $25 billion by 2029 and potentially accounting for 10-15% of global skin care sales.

All told, The Yield Growth Corp. has 26 new products in stability testing with an additional 13 ready to begin testing in the coming weeks. These include six essential oil perfumes, four natural remedy blends with essential oils, foot cream and hand cream made with proprietary hemp root oil and exotic botanicals. Yield Growth has also developed eight men's products, including four essential oil colognes, shaving cream, hair balm, beard oil, and eight white label versions of men's products without hemp root oil.

Yield Growth CEO Penny White says that management is negotiating more licensing and distribution agreements that should be finalized by the end of 2019. "Our continued development of our catalogue of hemp formulas for CBD and THC infusion supports our international licensing strategy," Mrs. White commented in a news release on the activity.

Success in Europe

As it expands its product bag, Yield Growth is also widening its sales channels. Recently, the European Union approved a Compliance Certificate for the Urban Juve Balance Face Moisturizer with Hemp Oil. The face moisturizer is the third Urban Juve product officially registered in Europe, joining the brand's Anti-Aging Serum and Lip Balm. Another eight products are in the registration process, with expectations approvals will start flowing in within a month.

Furthermore, the company received a trademark from the E.U. protecting its Urban Juve name. With over 508 million citizens, the E.U. represents a substantial growth opportunity for Yield Growth, so protecting the IP is imperative.

The green light to commercialize the new face moisturizer is perfectly timed, as the product is being featured in Vogue Beauty Highlights in the November issue of UK Vogue, which will put the product in front of the magazine's 4.1 million readers.

OMG(3)…South America Too

At the end of August, Yield Growth's subsidiary Urban Juve Provisions, entered an exclusive distribution agreement with Organic Medical Growth OMG3. Per the pact, OMG3 has exclusive distribution rights for Urban Juve products in Colombia and Brazil for a period of five years.

Distribution of the Urban Juve Balance Face Moisturizer with Hemp Oil, Ritual Body Oil and Anti-Aging Serum will first begin in Colombia. Subsequently, registrations will be submitted to get Urban Juve products into more South American countries. The goal is to tap a $32 billion Latin America cosmetics market by extending the distribution agreement to maximize OMG3's reach and put Urban Juve goods in at least 44,000 retail points which OMB3 has access to.

"With our new distribution alliances in place, Urban Juve products may soon become part of the daily skin care rituals for consumers in Europe and South America," commented White.

According to OMG3 CEO Jorge Diaz, the future holds big plans for the two companies. "In addition to creating in-house and co-branded hemp seed and cannabis-based product lines, our strategy is to bring major international brands to the market in the areas of cosmetics, therapeutic and pharmaceutical products," he said in a statement.

OMG3, a Canadian holding company, owns 100% of Estado Verde S.A.S, a Colombian company that has cannabis related licenses and permits, including the license for the cultivation of Psychoactive Cannabis (THC) and the License for the cultivation of Non-Psychoactive Cannabis (CBD). OMG3 has secured additional licenses by signing agreements with licensed producers in Colombia.

OMG3 has entered into a joint venture for a 4,000 hectares hemp production in Colombia as it positions itself to become the largest producer and distributor of cannabis products in South America, making it an ideal partner for Yield Growth to scale rapidly across the continent.

https://seekingalpha.com/pr/17635864-europe-s...-cfn-media

Better Plant Sciences Inc. (VEGGD) Stock Research Links

VEGGD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Occidental Bets Big on Argentine Sunflower Boom

Updated Category News Views 4

The Sunflower Seed Gamble When a company like Occidental Resources plunks down $200 million for sunflower seeds, you sit up and take notice. We're talking 300,000 metric tons of those little yellow gems sourced from Argentina, which according to the Rosario Board of Trade, is rolling in a whopping 6.6 million metric tons of sunflower product this year. Doesn't sound like...

Continue Reading
Cracking Down on Insider Trading: Legal vs Illegal

Updated Category News Views 8

Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...

Continue Reading
Chicago Nurses Fight for Unionization Amid Tensions

Updated Category News Views 7

Nurses in Chicago Make a Stand for Union Representation When healthcare workers start flexing their collective power, it signals brewing trouble not just for management but the entire system. Those nurses over at Endeavor Health in Chicago are fed up, and, frankly, I can’t blame them. On October 23, they’re gathering to make a big move—you know, filing for a union...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 2

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
MISO Unveils Major Energy Grid Project in Iowa

Updated Category News Views 7

Ameren's Game Plan in Iowa There's always something cooking in the energy grids, and this time, MISO's picking up the phone to call a heavy-hitting consortium. Ameren Corp, which flies under the NYSE as AEE, teams up with GridLiance and Dairyland Power Cooperative to kickstart an ambitious grid venture in Iowa. Now, if you're a betting trader, you'd want to size up how...

Continue Reading
Ohas Unveils £1.5M Health Clinic in London

Updated Category News Views 3

Ohas Steps into the Healthcare Spotlight Ohas is setting its sights on the UK healthcare scene with a new clinic launching in London come January 2027. This isn’t about throwing another dull clinic into the mix. No, it’s about changing the narrative on how we handle health. Founded by health tech entrepreneur Richard Chambers and NHS GP Dr. Luke Pratsides, Ohas is...

Continue Reading
MiniTool ShadowMaker 5.0: New Cloud Sync Feature

Updated Category News Views 5

Pushing the Boundaries with Cloud Sync Another day, another software upgrade. MiniTool ShadowMaker has jumped to version 5.0, throwing in a new Cloud Sync feature for Google Drive and OneDrive. Now, you might not be jumping out of your chair with excitement just yet, but hear me out. For those who fiddle with Windows backup and file sync often enough to owe Microsoft a...

Continue Reading
CardVault by Tom Brady Expands to Pittsburgh

Updated Category News Views 2

Tom Brady’s CardVault Hits Pittsburgh’s Historic Strip District Pittsburgh just got another feather in its cap with CardVault by Tom Brady marking its 20th store at The Terminal. As if this city needed more sports excitement! Pittsburgh, with its die-hard Steelers, Penguins, and Pirates fans, snags a premium spot for sports collectibles. A Prime Spot for Serious...

Continue Reading
MSG Rangers Joining S&P SmallCap 600: Key Moves

Updated Category News Views 7

MSG Rangers Takes Center Ice—In the Market Here we go—MSG Rangers (NYSE: MSGR) is sliding into the S&P SmallCap 600 like a puck on fresh ice, ready to switch places with Arbor Realty Trust (NYSE: ABR) come October 27. Now, that's not just a game changer for MSGR, but also throws some shuffle onto the board for investors in these organizations. We've got Madison Square...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 5

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading

Top 5 Most Recently Viewed Articles

Minerals Technologies Reveals Q3 Call Details and Insights

Updated Category News Views 147

Minerals Technologies Inc. Schedules Third Quarter Conference Call NEW YORK, September 2025 - Minerals Technologies Inc. (NYSE: MTX), a premier technology-driven specialty minerals entity, is excited to announce the forthcoming release of its financial results for the third quarter of the year. These results will be disclosed after market close on a designated Thursday,...

Continue Reading
How a $100 Investment in BALL Stock Could Grow Over Time

Updated Category News Views 58

Understanding the Long-Term Growth of BALL Stock Over the last two decades, Ball Corporation (NYSE: BALL) has proven to be a solid investment choice, outperforming the broader market by an impressive margin. With an average annual return of 9.9%, investors have seen remarkable growth, illustrating the benefits of long-term investing. The Impact of Compounded Returns The...

Continue Reading
Rosedale Federal and CorServ Unveil Advanced Credit Card Solutions

Updated Category News Views 160

Rosedale Federal and CorServ Collaboration Rosedale Federal Savings & Loan Association has entered a significant partnership with CorServ, a pioneer in payment card solutions. This collaboration aims to transform the credit card experience for both its business and consumer clients, making banking more accessible and convenient. With an extensive history dating back to...

Continue Reading
Fotona Welcomes Daniel Larko as New VP & General Manager

Updated Category News Views 215

Fotona Appoints Daniel Larko as Vice President & General Manager Fotona, a renowned name in medical laser technologies for aesthetics, surgery, dermatology, gynecology, and dentistry, has announced the appointment of Daniel Larko as its new Vice President and General Manager for North America. This strategic move marks a significant step in advancing the company’s...

Continue Reading
Iridex Reports Encouraging Q1 2025 Financial Performance

Updated Category News Views 210

Iridex Unveils Early Financial Outcomes for Q1 2025 Iridex Corporation (Nasdaq: IRIX), recognized for its groundbreaking laser-based medical solutions, has reported intriguing preliminary results for the first quarter of 2025. The company specializes in advanced treatments for glaucoma and retinal diseases, making significant strides in the medical field. Overview of...

Continue Reading